// App-Quantinova.ai

SU-OR40 : Characteristics and Outcomes of Pregnancy-Triggered Atypical Hemolytic-Uremic Syndrome (aHUS): Global aHUS Registry Analysis

Researchers

Presenter

  • Fakhouri Fadi

Principal Investigators

  • Miller Benjamin

  • Scully Marie

  • Ardissino Gianluigi

  • Al-Dakkak Imad

  • Rondeau Eric

Medical Centers

  • University of Lausanne (UNIL), Lausanne, Switzerland

  • Scott, Alexion Pharmaceuticals, Inc., Boston, Massachusetts, United States

  • Kings College London, London, United Kingdom

  • Center for HUS Control Prevention and Management Milan Italy

  • Hopital Cochin, Paris, France

Locations

  • Switzerland

  • United States

  • United Kingdom

  • Italy

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Atypical hemolytic uremic syndrome

  • End stage renal disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved